Jacqueline Linnes, the Marta E. Gross Associate Professor of Biomedical Engineering and director of the College of Engineering Honors Program, and Peristera Paschou, professor in biological sciences and associate dean in the College of Science, have been selected for the Class of 2022-2023 of Drexel University’s Executive Leadership in Academic Technology, Engineering and Science (ELATES) program.

Sarah Libring, a Ph.D. student in the Weldon School of Biomedical Engineering, is closing the chapter on her legacy made at Purdue University.

Sarah was first exposed to engineering through the PLTW (Project Lead the Way) program in her high school. Around the same time, she watched a TED talk about regenerative medicine work and discovered the interdisciplinary field of biomedical engineering. While pursuing her B.S. in biomedical engineering at Rutgers University, Sarah conducted research through the Rutgers Chemical and Biochemical Engineering Department and through the Rutgers Biomedical Engineering Department, publishing work from both laboratories. She also participated in two REU (Research Experiences for Undergraduates) programs at the University of Texas at Austin and Purdue University. Through these endeavors, she fostered research interests focused on understanding cellular responses to traumatic environments, such as during wound healing and cancer formation, and decided to continue research through a Ph.D. program.

The Engineering in Medicine Institute is a flagship effort combining the strengths of IU School of Medicine and the Purdue University College of Engineering. The goal of the new Engineering in Medicine Institute is to create an environment between Purdue Engineering and IU School of Medicine that fosters innovation and translation, as well as partnership with premier industries in Indiana. To maximize the rapid success of the Engineering in Medicine Institute, there is an initial focus on five targeted areas: cardiovascular health, cancer, musculoskeletal health, otolaryngology and pediatrics. The goal of these research collaborations is to develop novel technologies and approaches that will lead to innovative approaches and engineered systems for improved patient care.

Medical devices are a nearly $500 billion global market and encompass technologies such as heart valves, joint replacements, medical imaging equipment, diagnostic tests, digital health technologies contained within smart watches, and thousands more. These are complex products that often take many years of development and testing before they are approved to treat patients. The rapid expansion of medical technologies has increased the demand for regulatory professionals who understand both the science of medical device development and the regulatory processes that are in place to protect and promote public health.

Rescue Biomedical has received a Fast-Track Small Business Innovation Research grant from the National Institutes of Health to develop its technology that detects when a person is overdosing on an opioid and delivers naloxone to reverse the action.

The new program will offer all courses fully online, allowing students to complete their degree virtually from anywhere in the world.

Sang Hoon Um, a doctoral student in the Weldon School of Biomedical Engineering at Purdue University, was awarded the school’s Fearnot-Laufman-Greatbatch Award for best Summer Seminar presentation.

The vision of Purdue University biomedical engineer Chi Hwan Lee to develop specialized smart soft contact lenses that can accurately measure intraocular pressure (IOP) in a person's eye could be the latest answer to stopping glaucoma-related blindness.

If you’ve been around BME during this past year, you may have heard about the EMBRIO Institute. Led by BME Head, David Umulis, EMBRIO is Emergent Mechanisms in Biology of Robustness, Integration, and Organization Institute. Funded in late 2021 as an NSF Biology Integration Institute, EMBRIO aims to determine how living systems integrate “orthogonal” signals such as chemical and mechanical stimuli to develop responsive phenotypes that coordinate cell and tissue structures for survival and function. We are employing quantitative imaging and simulation to bridge diverse biological systems to penetrate a Rules of Life question—"How are multimodal signals integrated across scales to coordinate the robust cell biological and morphogenetic responses needed to survive?”. EMBRIO’s interdisciplinary team is ideally positioned to penetrate these problems with expertise in modeling, simulation, experimental biology, and educational research. The answers to these questions have implications for human health and longevity.

This fall 24 first-year medical students embarked on their studies with the Indiana University School of Medicine here on the Purdue, West Lafayette, campus. This Purdue University, Indiana University School of Medicine partnership is more than 50 years strong, having been launched with a one-year pilot program in 1968. By 1980, a second year had been added, and by 2014, medical students could stay for all four years of their medical education, including clerkships at local hospitals.